Latest Research And Development News

Page 62 of 63
Biotron Limited has engaged US-based C14 Consulting Group to drive strategic partnerships for its antiviral drug portfolio, including lead candidate BIT225, while advancing its Hepatitis B research.
Ada Torres
Ada Torres
24 Jan 2025
Paradigm Biopharmaceuticals has secured a $6.3 million R&D Tax Incentive refund, lifting its cash reserves to $31 million and reinforcing its push into Phase 3 osteoarthritis clinical trials.
Victor Sage
Victor Sage
24 Jan 2025
Australian Silica Quartz Group reports promising gold intersections at Koolyanobbing Metals Project and progresses its Quartz Hill silica project with positive metallurgical results and strategic funding.
Maxwell Dee
Maxwell Dee
24 Jan 2025
VHM Limited has secured ministerial endorsement for its Goschen Project Environmental Effects Statement, paving the way for a Final Investment Decision and targeted production in 2026. The company also advanced financing and strategic appointments to support its development trajectory.
Maxwell Dee
Maxwell Dee
24 Jan 2025
Raptis Group Limited reported a positive net cash inflow from operating activities of $54,509 for the quarter ended December 31, 2024, ending with $303,102 in cash and equivalents. The company recorded no investing or financing cash flows during the period.
Claire Turing
Claire Turing
24 Jan 2025
InhalerX Limited reported a negative cash flow for the December quarter despite securing a substantial $38.5 million funding facility aimed at advancing its clinical trials. The company has yet to draw on this facility, maintaining a cautious cash position as it progresses its drug development programs.
Ada Torres
Ada Torres
23 Jan 2025
Nyrada Inc. reports promising preclinical results for its lead drug NYR-BI03, showing an 86% cardioprotective effect, alongside a strong financial position bolstered by a AU$3.29 million capital raise. The company has submitted its Phase Ia clinical trial package, setting the stage for human testing.
Ada Torres
Ada Torres
23 Jan 2025
Talius Group reports a robust December quarter with $4.4 million revenue, positive operating cash flow, and a strategic $2.5 million capital raise, positioning the company for strong growth in 2025 amid evolving aged care legislation.
Ada Torres
Ada Torres
23 Jan 2025
Rhythm Biosciences reported a strong December quarter, securing a $3.2 million R&D tax incentive and completing a strategic acquisition of Genetype assets, positioning the company for commercial expansion in cancer diagnostics.
Ada Torres
Ada Torres
23 Jan 2025
BPH Global has completed its acquisition of Indonesian seaweed assets, establishing a wholly owned subsidiary and launching joint operations aimed at expanding seaweed cultivation and bio-stimulant product development across Asia.
Ada Torres
Ada Torres
23 Jan 2025
Icetana Limited reports a sharp decline in cash flow for the December quarter, offset by plans for an underwritten rights issue to bolster funding and expectations of improved customer receipts in coming quarters.
Sophie Babbage
Sophie Babbage
23 Jan 2025
Matsa Resources has completed a 767m diamond drill hole at Fortitude North, designed to validate a novel seismic model indicating potential gold mineralisation. Early geological observations support the seismic data, setting the stage for further exploration.
Maxwell Dee
Maxwell Dee
22 Jan 2025